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INTRODUCTION 
"What is powerful for good 
can be potent for evil" 
William Boyd, Textbook of 
Pathology (1961) 
Gentian violet and related compounds still occupy an important position in 
topical therapy because they are powerful and time-honoured antibacterial 
and antifungal agents. "The triphenylmethane dyes are in Europe among 
the most used dermatological topical agents" (Bielicky & Novak 1969). 
Generally gentian violet or crystal violet are preferred. They are usually 
administered as paints in 0. 5 - 2% concentration in aqueous solution. They 
are used primarily or when newer preparations are not tolerated or are 
ineffective. The most commonly recommended indications for their use, 
as stated in standard textbooks and review articles, are: cutaneous and 
mucosal candidiasis, ringworm infections, primary and secondary bacte­
rial skin infections, and leg ulcers (Pharm. Svec. 1967, DeWeese & 
Saunders 1968, Brody 1970, Meinhof 1970, Goodman & Gilman 1970, 
Domonkos 1971, Fitzpatricketal. 1971, Rook, Wilkinson & Ebling 1972). 
Such treatment is generally considered harmless. 
This work was inspired by the clinical observation that some patients 
treated topically with gentian violet for mycotic infections developed severe 
irritation and even necrotic ulcers. These reactions could not easily be 
attributed to the primary or a superimposed infection. Consulted text­
books had no information whatsoever about irritant reactions to gentian 
violet. A thorough survey of the literature revealed only a few cases of 
a similar kind and disclosed that little is known about the influence of gen­
tian violet and related compounds on normal and regenerating tissues. It 
may well be that gentian violet also induces substantial but clinically less 
dramatic side effects which influence tissue repair. 
5 
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n(C2H5 )2 (HS04) 
Bri I liant green 
Fig. 1. Chemical structure of some triphenylmethane dyes. 
Chemical data 
The entangled nomenclature of t he dyes justifies a short description of 
those used in this investigation. 
Gentian violet, belonging to a group of d yes which are substitution products 
of t he triphenylmethanes, is a mixture of h exa- and penta-methylpararos-
aniline chlorides (Disp.US 1955, Lillie 1969), The composition is now poorly 
defined. In fact, various companies may supply different mixtures with 
this label. Accordingly, the name is no longer considered suitable for a 
certified stain (Lillie 1969). In clinical practice, however, the name is 
still retained though the chemist's shops at least in Sweden usually supply 
hexamethylpararosaniline chloride (crystal violet) when gentian violet is 
requested (Pharmacop. Nord. 1964). 
Crystal violet (C.I. 42555) or methylrosanilinum (Pharm. Nord. 1964) is 
a pure compound of h examethylpararosaniline chloride (Merck Index 1960, 
Lillie 1969). It is a basic dye (pK 9. 4). The pH of th e medium affects the 
degree of io nization of c rystal violet (Goldacre & Phillips 1949). In the pH 
range 6. 5 - 8. 5 the dye is 100% ionized (Fry 1957). Molecular weight 408. 
Maximum light absorption 589 - 593 nm. At 26°C, its solubility in water 
is 1. 7% and in alcohol 13. 9% (Lillie 1969). The molecular configuration is 
depicted in Fig. 1. The benzene rings are not located in the same plane 
(Buckley & West 1970). 
Methyl violet (C. I. 42535) is a mixture of t etra-, penta- and hexa­
methylpararosaniline chlorides (Lillie 1969). Methyl violet 2B is princip­
ally pentamethyl-p-rosaniline chloride (Fig. 1), which has a molecular 
weight of 394 (Merck Index 1960). 
Brilliant green (C. I. 42040) is another basic dye, a diaminotriphenyl-
methane derivative in the form of th e acid sulphate (Fig. 1). Molecular 
weight 483. Light absorption maximum 628 - 631 nm. (Lillie 1969). 
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The writer has used crystal violet for the experiments in this thesis 
(I - V). The commercial product (E. Merck, Darmstadt), pharmaceuti­
cal grade, contains not less than 96% of he xamethylpararosaniline chloride 
and has a small admixture of le ss methylated derivatives (penta-, tetra-). 
Methyl violet 2B (II) and brilliant green (I, II, IV) have also been studied. 
SURVEY OF THE LITERATURE 
Historical background 
Churchman, who had investigated the antibacterial properties of t he aniline 
dyes, reported in 1912 that gentian violet has a selective action on most 
gram-positive bacteria. It is bacteriostatic in dilutions of 1:10® in test 
4-5 tube and agar plate, and bactericidal when diluted 1:10 . Support for the 
rational of a therapeutic usage came from Russel (1914). He found that 
certain animal tissues were more resistant to the actions of the dye than 
the bacterial test organism (B. subtilis). Gentian violet was soon tried on 
patients as a topical antiseptic. In a few patients with severe infections, it 
was even injected in infected joints and injected intravenously for the treat­
ment of septicemias, with fair results (c. f. Sutton 1938). 
In 1920, Churchman emphasized the value of gentian violet in the treatment 
of wounds infected with gram-positive bacteria. The following years, 
gentian violet attained widespread use as a topical remedy (c. f. Sutton 
1938). Candidiasis soon became another indication for the use of gen tian 
violet (Faber & Dickey 1925), as it inhibits the growth of C. albicans in 
dilutions of 1:1 06 (Gomez-Vega 1935). The antifungal properties of gen tian 
violet against strains of Epidermophyton, Trichophyton (Gomez-Vega 1935, 
Geiser 1955) and Microsporon (Geiser 1955) are somewhat weaker than 
against C. albicans, but sufficiently effective to be employed for the 
control of superficial dermatomycoses. 
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There were, however, some studies indicating that gentian violet under 
experimental conditions might exert harmful effects on t issues. Gentian 
violet killed rabbit spleen cells in vitro at concentrations not killing 
S. aureus (Lambert & Meyer 1925-26). At a concentration of 1:800, 
gentian violet completely inhibited the outgrowth of c ells from embryonic 
chick skin expiants (German 1929). Clinicians, however, witnessed the 
efficacy and safety of gentian violet for topical use. In 1938, Sutton sur­
veyed the literature and his own experiences with gentian violet. He 
claimed that aqueous solutions of 0. 1-2% gentian violet are not irritating, 
and that he was not aware of an y hypersensitive reaction. He concluded: 
"I have found it valuable in the treatment of monilial infections, especially 
pruritus vulvae and pruritus ani of t his origin, and the cutaneous eruptions 
dependent on them; of im petigo, infectious eczematoid dermatitis, infan­
tile furunculosis and secondarily infected eczema, infantile or adults; of 
Vincent's angina, leg ulcers and ulcers following third degree burns, 
and of recurrent dermatomycoses including tinea of th e hands and feet. " 
In 1933, Aldrich introduced gentian violet (1%) for the topical treatment of 
burns, replacing tannic acid. An eschar is formed which seals the burn 
from contamination, reducing the high frequency of gr am-positive infec­
tions, and eliminates the loss of flu ids through the serous ooze. Following 
the introduction of this treatment the burn mortality at Johns Hopkins 
Hospital dropped from 42 to 13% (Aldrich 1937). A com bination named 
"triple dye" of gentian violet, brilliant green and acriflavin eliminates 
gram-negative bacteria as well (Aldrich 1937). Local treatment of burns 
with triple dye was continued into the 1940's (Harkins 1942), when the 
modern principles of s ystemic and local burn therapy successively were 
introduced. At the same time, it was reported that topical burn remedies 
then commonly employed, including gentian violet and "triple dye", re­
tarded the healing of superficial wounds and burns in man (Cannon & Cope 
1943, Dingwall & Andrus 1944) and produced necrosis when painted on ex­
posed rat muscle (Baker 1944). It was also found that gentian violet in con-
4 
centrations about 1:10 inhibited the phagocytic actions of le ucocytes 
(Welch & Brewer 1942). The findings of these clinical and laboratory stu­
dies did not seem to have any obvious impact on the continued widespread 
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use of the triphenylmethane dyes. 
Adverse effects from therapeutic usage 
The facts that the underlying disease is masked and that solutions are messy 
and may stain the patient's clothes and bedlinen are obvious drawbacks of 
dye treatment. 
Sensitization to triphenylmethane dyes has been reported, but is considered 
to occur very rarely (Rook, Wilkinson & Ebling 1972). There are only a 
few patients reported with delayed eczematous allergy to gentian violet 
(Goldstein 1940, Epstein 1958, Bielicky & Novak 1969). Cross-sensitization 
may exist between chemically related triphenylmethane dyes (Bielicky & 
Novak 1969). 
Immediate hypersensitivity reactions (anaphylactic chock) have occurred 
due to sensitization to topically applied methyl green (which is crystal 
violet with an extra ethyl group) (Francois et al. 1971). 
Irritant reactions have also been observed. Since the introduction of in ­
delible pencils more than 70 years ago, ophtalmologists and surgeons have 
been aware of t he risk for tissue necrosis following accidents to the eyes 
or skin (c. f. Strandell 1950). The causative agent is considered to be gen­
tian violet, which may be present in a concentration as high as 30% 
(Hosford & Smith 1952). "Epidemic" nosebleed in apple packers was 
caused by dust released from apple-packing trays coloured with gentian 
violet (Quinby 1968). Slotkowsky (1957, 1966) reported two infants out of 
several with thrush, who developed tender ulcerative or gelatinous-like 
lesions of oral mucosa following painting with 1% aqueous gentian violet 
for 7 weeks and 6 days. He was also able to produce similar lesions in 
rabbit oral mucosa by application of 1% aqueous solution of gen tian violet 
for 2 weeks. In 1968, John reported 2 infants treated 1 and 2 weeks with 
0. 5% gentian violet for oral candidiasis who developed necrotic ulcerations 
of th e oral mucosa. 
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Jennison & Llywelyn-Jones (1957) treated 36 patients suffering from can­
didal vaginitis with 1% aqueous gentian violet on three alternate days. 
Six of th e women developed a local reaction of t he vagina which made it 
necessary to stop treatment. Clabaugh (1968) has described a method to 
remove tattoo-marks, utilizing superficial dermabrasion followed by da ily 
paintings with 2% aqueous solution of ge ntian violet. The reason for using 
the dye is not specified but it appears that it was intended to serve as an 
antiseptic. This procedure may result in a cutaneous necrotic inflammatory 
reaction (Hersle 1970). Sutton (1938) reported 2 cases of scar tattooing 
with a purple colour resulting from contact of gen tian violet with granula­
tion tissue. 
Gentian violet taken orally as a vermifuge may cause diarrhoea, nausea and 
vomiting, suggesting a local effect on t he gastrointestinal mucosa 
(Beckman 1961, Martindale 1967). 
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AIMS OF THE PRESENT STUDY 
The aims of t he present investigation of so me cationic triphenylmethane 
dyes were to study: 
1) the clinical picture of le sions caused by such dyes in man (I ), 
2) the influence of ep icutaneous dye application on normal skin and 
on skin with a disturbed penetration barrier ("stripped" epider­
mis) (I), 
3) the effect on cellular proliferation in vitro (II ), 
X / 4) the effect on the formation of gra nulation tissue and on the 
rate of wound he aling (III, IV), 
5) the early metabolic reactions of gr anulation tissue following 
dye exposure ( V ). 
X / Granulation tissue: a newly formed, highly vascularized connective 
tissue with a component of a cute inflammatory exudation (Cameron 
1969). 
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INVESTIGATIONS 
CLINICAL PICTURE OF LESIONS CAUSED BY TRIPHENYLMETHANE 
DYES IN MA N (I) 
Three patients, out of several, are described who developed necrotic 
lesions after the application of 0. 5-1% gentian violet in aqueous solution 
to the skin of th e scrotum, the napkin area of an infant and the vulva. 
The first sign of an untoward reaction in the patients was the appearance 
after up to 10 days of intensely painful, somewhat swollen spots. A sli ght 
exudation occurred, followed by sloughing of t issue and resulting in super­
ficial and very tender ulcerations with a characteristic yellow (sometimes 
black) surface. In intertriginous locations, the ulcers sometimes merged 
to form large, denuded areas. Rapid healing followed cessation of gen tian 
violet treatment. 
Patch tests were performed on 2 of t he patients on normal back skin with 
1% gentian violet (the bottle, delivered from the hospital pharmacy, was 
labelled "gentian violet", but actually contained crystal violet) and 1% 
brilliant green in water. The patch tests showed negative results. 
Conclusion. Necrotic ulcerations may occur on injured skin painted with 
1% gentian violet in aqueous solution. 
EPICUTANEOUS DYE A PPLICATION ON NORMA L AND "STRIPPED" 
EPIDERMIS (I) 
Partial epidermal defects were made by stripping away the stratum cor-
neum with adhesive tape, as originally described by Pinkus 1951 (for re­
view, see Christophers 1972). Two human volunteers and 10 guinea pigs 
were used for these experiments. In man, immediately after stripping on 
the flexor surface of t he forearm, 1% gentian violet (crystal violet, vide 
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supra) in water was painted once a day for 2 days on half of the stripped 
area, the other half serving as control. Identical experiments were done 
with 1% brilliant green (aq. sol. ). The guinea pigs were stripped on the 
flank and immediately painted, 5 animals with 2% gentian violet (crystal 
violet, vide supra) and 5 with 2% brilliant green. Skin biopsies were taken 
from stripped areas after 1 and 5 days in man, and after 3 days in guinea 
pigs. 
Application of dyes to the stripped skin of man and guinea pig gave essenti­
ally the same result. A sequence of gross skin changes almost identical to 
that described in the patients occurred. All guinea pigs had developed ne­
crotic reactions after 2 days, but only in painted areas that had previously 
been stripped. In man, ulcerations were seen after 5 days in areas painted 
with gentian violet as well as brilliant green. Application of these dyes to 
the intact skin of g uinea pig or man (Björnberg & Mobacken 1972) produced 
no reaction. 
In man, hydropic degeneration of the basal layer with subepidermal vesicle 
formation and a polymorphonuclear leucocytic infiltration in the upper der­
mis was found in stripped areas 24 hours after the first dye application. 
After 5 days, there was total epidermal necrolysis. In guinea pigs, most 
epidermis was lost after 72 hours, and in some places subepidermal vesic­
les were seen. Small leucocytic and lymphocytic infiltrates appeared in 
the dermis. 
Conclusion. Reactions similar to those seen in clinical practice can be 
reproduced by painting "stripped" - but not "unstripped" - normal skin 
in man and guinea pig. 
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TRIPHENYLMETHANE DYES AND CELLULAR PROLIFERATION 
IN VITRO (II) 
In monolayer cultures, one fibroblast-like cell line from human dermis 
was exposed to crystal violet, brilliant green and methyl violet 2B at con-
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centrations of 1-100 jig/ml (1:10 - 1:10 ) for 3 days. Epithelial-like cells 
of hum an origin (HeLa-cells) were similarly exposed to crystal violet. 
Single-cell suspensions of c ultures were electronically analysed for 
cell-counts. For subsequent studies, the skin fibroblast-like cell line and 
crystal violet at a concentration of 10 p.g/m.1 were chosen. In one series 
of e xperiments the cell number of cu ltures continuously exposed to this 
dye was measured 24, 48, 76 and 96 hours after subculture. In another 
experiment, crystal violet was added to dense, topo-inhibited, somewhat 
tissue-like 12-days-old cultures, which were analysed 2 days later. In a 
third series of e xperiments, crystal violet was added to cells in growth 
media containing heparin (conc. 0. 1-200 IU/fail), chondroitin sulphate 
(100jug/ml), Na-dextran sulphate (lOOjig/hil) or varying concentrations of 
serum (2. 5, 10 and 40% v/v). The cells were counted 3 days later. In the 
last experiment the effect of va rious durations of exposure to crystal vio­
let (5, 20, 80, 320, 1280 minutes) was tested by small inocula of c ells 
and counting the number of m ulticellular colonies 10 days later. 
Three days' exposure to all dyes markedly reduced the number of c ells. 
The most pronounced effect regularly occurred at an intermediate concen­
tration (10 jig/ml). The reduction in cell number was progressive, being 
substantial, already after 24 hours. The addition of c rystal violet to 12-
days-old cultures caused a marked decrease of ce lls in the originally dense 
cultures. When the medium contained 40% serum or when the polyanionic 
substances heparin, chondroitin sulphate or Na-dextran sulphate were 
added to the growth medium, the cytotoxic effect of c rystal violet was re­
duced. Already 5 minutes' exposure to crystal violet resulted in a signi­
ficant reduction of the number of ce ll colonies. Increasing exposure times 
resulted in further decrease of ce ll colonies. 
15 
Conclusions. Crystal violet, methyl violet 2B and brilliant green were 
strongly cytotoxic in vitro at concentrations as low as 1 jig/ml (1:10^), 
Exposure to crystal violet (10 jig/ml) for 5 minutes was enough to hamper 
the multiplication of ce lls. The toxicity of c rystal violet was pronounced in 
densely as well as in sparsely populated cultures. The cytotoxic actions 
of c rystal violet were markedly reduced by high serum concentration and 
polyanions such as heparin and chondroitin sulphate. 
TRIPHENYLMETHANE DYES AND CON NECTIVE TISSUE REGENERATION 
This problem was evaluated in two different models. 
Subcutaneous sponge implantation (III ) 
Viscose cellulose sponges were used as an inductive matrix for granula­
tion tissue, as described by Viljanto (1964). Each sponge was cut as a cy­
linder and sectioned into 2 equal halves (each lxlxl cm), which were 
sewn together in their original position. One anterior and one posterior 
incision was made under sterile conditions in the dorsal midline of m ale 
rats. Through each incision one sponge was implanted subcutaneously on 
each side. In 4 groups of an imals, one sponge in each pair was exposed 
immediately before implantation to an aqueous solution of c rystal violet 
and the other to sterile water. The dye was used in dilutions of 1:100, 
1:1, 000, 1:2, 000 and 1: 10, 000. In a fifth group, the subcutaneous wound 
pockets were correspondingly treated with crystal violet (1:2, 000) for 5 
minutes and the sponges soaked in sterile water. 
Ten days after implantation, the sponges were removed and carefully freed 
from surrounding tissue. The suture holding the halves of th e implant to­
gether was removed. The breaking load of the newly formed tissue con­
necting the 2 halves of ea ch sponge was measured with a tensiometer. The 
dry weight of the tissue within the sponge was determined. Paired compa­
risons were used for each pair of sp onges. In additional animals, simi­
larly treated, implanted sponges were used for histology. 
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Exposure of the tissues either by dyeing the sponge or the wound pocket 
resulted in a marked decrease of the strength of the tissue bridging the 
narrow cleft between the 2 halves of e ach sponge. The dry weight of tissue 
contained in the sponge was significantly reduced in sponges treated with 
crystal violet 1:10, 000, and in sponges implanted in a dye-treated wound 
pocket. Histological examination disclosed considerable ingrowth of con­
nective tissue into control sponges. Dye-exposed sponges, irrespective of 
dye concentration, seemed to contain no connective tissue at all, the 
sponge pores being occupied by serofibrinous oedema and inflammatory 
cells. The sponges were not serially sectioned. Therefore the occurrence 
of some connective tissue at least in sponges least exposed to crystal vio­
let cannot be excluded. Necrotic areas on skin overlying a dye-soaked 
sponge were observed in 4 rats out of the 10 treated with the highest con­
centration of crystal violet, 1:100. 
Conclusion. Crystal violet in concentrations well below those used 
clinically markedly inhibited the formation of g ranulation tissue in cellu­
lose sponges implanted subcutaneously for 10 days. 
Wound healing (IV) 
Two standardized skin incisions were inflicted symmetrically on the back 
of rats. The incisions, 6 cm long, were perpendicular to the skin surface 
and penetrated the subcutaneous muscle. One wound was exposed for 5 
minutes to an aqueous dye solution and the other to sterile water. This 
duration had experimentally been found sufficient to interfere with cell 
multiplication in vitro (II ). The incisions were closed by continuous silk 
suture, the wound edges being carefully adapted. Crystal violet was used 
in dilutions of 1:1, 000, 1:2,000, 1:10,000, 1:20,000, and 1:50, 000. Bril­
liant green was diluted 1:2, 000. After 7 days the sutures were removed 
and the breaking load of each wound was determined in situ with a tensio-
meter. The percentage difference between dye-exposed and control wound 
in each rat was calculated and used for statistical analysis. Inter-
individual variation was avoided by comparing control and test wounds in 
the same animal. 
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In another experiment, groups of a nimals were examined for wound strength 
after healing periods of 7, 10, 14 and 21 days after exposure to crystal vio­
let 1:2, 000. In additional animals, wound biopsies were taken for histology. 
For each animal coded slides with specimens from the test and the control 
wound were compared. The degree of t he inflammatory reaction, the pro­
liferation of fi broblasts, the formation and structure of co llagen fibres and 
the formation of gr ound substance were evaluated. 
Wounds treated with brilliant green or with all tested concentrations of 
crystal violet had significantly reduced values for breaking load 7 days 
postoperatively. The results from the animals treated with crystal violet 
1:2, 000 and followed for 3 weeks demonstrated a lengthened lag phase and 
consequently a delay of t he onset of t he period of fib roplasia. Once started, 
however, the rate of ga in of b reaking load was almost as rapid in dye-
treated as in control wounds. At 3 weeks postoperatively, the test wounds 
had still not reached control wound values. 
Histologically, the dye-treated wounds exhibited an intensified and pro­
longed acute inflammatory reaction. After 3 weeks' healing, the amount 
of fi broblasts and collagen seemed roughly equal in wounds treated with 
dye and water. There were, however, qualitative differences: in dye-
treated wounds, the fibroblasts and the collagen fibres were less mature. 
Conclusions. One application of c rystal violet to incisional skin wounds 
before suturing retarded the development of s trength in the wounds for 
at least 3 weeks. The dye prolongs the lag phase by inducing an increased 
and prolonged acute inflammatory reaction, thus retarding the onset of 
fibroblast proliferation and collagen formation. 
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EARLY METABOLIC REACTIONS OF DYE-EXPOSED GRANULATION 
TISSUE (V) 
Albino rabbits were used as donors of gra nulation tissue, obtained from 
stainless steel wire mesh cylinders implanted subcutaneously 3 weeks pre­
viously according to Holmström (1973). The tissue within the cylinder was 
placed in an ice-cold buffered incubation medium, sliced, weighed and 
divided in samples about 500 mg. Experimental samples were exposed to 
5 6 
crystal violet 10 jig/ml (1:10 ) or 1 fig/ml (1:10 ) (dissolved in the incuba­
tion medium) for 5 minutes at 37°C, and control samples correspondingly 
treated with the incubation medium. The determination of oxygen uptake 
of t issue samples started either immediately after exposure, or 30 minu­
tes later. The method was a slight modification of th at recently described 
14 by Holmström and co-workers (1974). The incorporation of C-proline 
into proteins and collagen hydroxyproline was estimated by incubation with 
14 o ö^wCi L-proline- C(U) at 37 C for 2 1/2 hours. The RNA-synthesis was 
determined following exposure of t issues to 50 jiCi cy tidine-5-3H at 37°C 
3 for 2 1/2 hours and isolation of RNA. Incorporation of H-cytidine into 
RNA was taken as a measure of new ly formed RNA. 
Exposure of s liced granulation tissue to crystal violet 1:10° for 5 minutes 
14 
caused a markedly reduced incorporation of C-proline into proteins as 
well as into collagen hydroxyproline. The synthesis of RNA was clearly 
reduced. The oxygen consumption rate was only slightly reduced as com­
pared to control samples when the assay started immediately after expo­
sure to the dye, but markedly lower in samples analysed 30 minutes later. 
6 14 With crystal violet 1:10 , the incorporation of C-proline into proteins 
and collagen hydroxyproline was reduced, but with this concentration of 
dye the difference from control samples was less. The synthesis of RNA 
and the oxygen consumption rate (assay starting 30 min. after exposure) 
were not affected. 
Conclusions. Granulation tissue slices exposed in vitro to crystal violet in a 
dilution of 1:10° has a decreased capacity to consume oxygen, to incorpo-
14 
rate C-proline into collagen and non-collagenous proteins and to synthe­
size RNA. 
DISCUSSION 
Gentian violet has been used as a topical antibacterial and antifungal agent 
for more than half a century and is still widely used (Pharm. Svec. 1967, 
Domonkos 1971, Rook, Wilkinson & Ebling 1972). Only a few reports of 
adverse effects of this remedy are available (see References in I) and text­
books of d ermatology regularly consider this treatment as having very few 
complications (e. g. Hellerström 1968, Domonkos 1971, Fitzpatricketal. 
1971, Rook, Wilkinson & Ebling 1972). Except for some few experimental 
studies showing a cytotoxic effect of ge ntian violet (Lambert & Meyer 
1925-26, German 1929, Welch & Brewer 1942) little is known about the in­
fluence of t his substance on living cells. The exact incidence of tissue da­
mage from cationic triphenylmethane dyes can only be discovered from 
well controlled, prospective studies. Search of t he literature has only re­
vealed one such study (Jennison & Llywelyn- Jones 1957). These authors 
found, in a clinical trial of n ystatin for candidal vaginitis, that out of a 
control group of 36 women treated with 1% aqueous gentian violet no less 
than 6 developed severe local reaction which necessitated cessation of 
treatment. Though this frequency appears high it points to the possibility 
that a considerable number of c ases with adverse tissue reactions to tri­
phenylmethane dyes are not recognized or not reported. Incomplete know­
ledge of th e influence of d yes on normal and reparative tissue increases 
the risk of a misinterpretation of th e clinical picture. Besides, the "index 
of su spicion" for unexpected adverse drug reactions is low with time-
honoured remedies. The clinical observation of m arked tissue reaction 
in some patients treated with gentian violet motivated analyses with dif­
ferent experimental models of th e possible tissue damaging effects of 
chemical compounds of this type. 
The standard method for screening and comparing the potential cutaneous 
irritancy of drugs and cosmetics is that described by Draize and co­
workers (1944) using rabbits. A c ritical review of t his method has been 
given by Rostenberg (1961). The method is unsuitable for studies of 
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coloured compounds since the tests are numerically scored by the degree 
of e rythema and oedema. A s imple method for studying coloured compounds 
is to apply the dye to intact and "stripped" (i. e. stratum corneum removed) 
guinea pig skin. This method has been used in the present investigation. It 
was found (I ) that crystal violet caused marked gross and microscopical 
changes when the dye was applied to "stripped" skin, thus tissue where the 
protective barrier has been removed. The microscopical changes were 
distinct and comprised necrosis of e pidermal cells, epidermo-dermal 
separation and dermal polymorphonuclear leucocytic infiltration. These 
features are characteristic of a primary irritant dermatitis (Hunziker 1969, 
Medenica & Ros tenberg 1971). No re action was observed when the dye was 
applied to skin with intact stratum corneum. 
The reactivity of gu inea pig skin to irritants approximates that of human 
skin (Davies, Harper & Kynoch 1972). Application of c rystal violet to skin 
in man using the same technique as described for guinea pigs resulted in 
similar gross and microscopical changes. 
The observations (I ) indicate that application of c rystal violet under certain 
conditions can cause serious tissue damage. Such conditions can be expec­
ted to occur in most instances of c linical use where infectious and inflam­
matory situations are at hand. The observations further indicate that the 
possibilities for penetration of t he applied dye into the tissue are of im por­
tance. Penetration is known t o increase with occlusion (c. f. Wahlberg 1973) 
- from dressings or natural body folds - and consequently an increased 
risk for tissue damage will exist in such situations. 
After the clinical and experimental observations of a tissue damaging effect 
of g entian violet this effect was studied more in detail by methods that allow 
quantitation. It was decided to study the influence of dy e on regenerating 
tissue, because this would closely approximate the clinical situation in that 
the process of r egeneration involves phases of in flammation and fibro­
plasia. 
Two methods, subcutaneous implantation of c ellulose sponges and breaking 
21 
load determinations of i ncised skin wounds, were used for study of t he 
regeneration of c onnective tissue. Both methods are well defined and allow 
quantitative determinations of t he influence of l ocally applied agents 
(Sandblom 1944, Viljanto 1964, Rydberg 1968, Brunius 1968). The tech­
nique of c ellulose sponge implantation (III ) demonstrated that exposure of 
the sponges or the tissue around the sponges to crystal violet resulted in 
increased inflammatory reaction and marked reduction of t issue formation, 
illustrated as persistent serofibrinous oedema in sponges and decreased 
strength of a defined tissue bridge in the sponge. These experiments thus 
confirmed and quantitated a tissue damaging effect of c rystal violet. Fur­
ther support for this negative influence was found in the study of b reaking 
load development in sutured skin wounds (IV) wh ich demonstrated signifi­
cant reduction in breaking load after local application to the wound edges 
of the dye. Microscopic study of the wounds revealed a prolonged and inten­
sified inflammatory reaction. The study of t he development of woun d 
strength over the period 7-21 days showed that this retardation of he aling 
was due mainly to a prolongation of the lag phase while fibroplasia, once 
started, proceeded at a fairly normal rate. However, breaking load was 
still at 21 days lower in dye-exposed wounds indicating that up to that time 
the delay in healing had not been compensated. These results, obtained 
from wounds healing by primary intention, should be valid also for open 
wounds (healing by secondary intention), as the principles of the healing 
process are the same (Schilling 1968). The observations thus support the 
findings by Cannon & Cope (1943) and Dingwall & Andrus (1944) of retarded 
healing of a braded or burned skin treated with gentian violet. 
Some degree of in flammatory reaction is required for optimal healing. 
Decreased as well as increased inflammation will cause impaired healing 
(Carrel 1921). The degree of in flammation optimal to healing is not de­
fined but empirically the most appropiate stimulus is "the clean sweep of a 
sharp cold knife" (Dunphy 1963). Merely the presence of s utures in such an 
incisional wound will add to the inflammation and impair healing (Brunius 
1968), but at the same time has the positive effect of a llowing primary 
healing. These mixed effects of a local factor can of c ourse also apply to 
the use of c rystal violet: the negative effect of t issue damage and the 
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positive antimicrobial effect. Observations similar to those in the present 
study have been reported by Rydberg (1968) as regards quaternary 
ammonium compounds with antibacterial effects. 
The tissue damage observed by the different experimental methods is the 
end result of t issue reaction to the dye. Elucidation of the mechanisms 
behind the dye impairment of t issue function required more sophisticated 
methods, such as tissue cultivation and biochemical analyses of regenera­
ting tissue. 
The study of t he influence of c rystal violet on human cells in vitro (II ) 
demonstrated that a short application of only 5 minutes already causes 
marked impairment of ce ll multiplication and also that, with longer expo­
sure, this impairment is increasingly pronounced. From the study it can 
further be inferred that the cytotoxic effect can be partly reduced by the 
addition to the medium of high concentrations of s erum or polyanionic tis­
sue components. The marked cytotoxicity of c rystal violet even in cultures 
with a reduced growth fraction indicates that the dye damages not only 
DNA-synthesizing cells but apparently also cells in other phases of the cell 
cycle. It might well be that crystal violet interferes with basic mechanisms 
of li ving cells. 
In a further attempt to analyse crystal violet's mechanism of ac tion (V), 
granulating tissue exposed to the dye was analysed biochemically and 
functionally by measurements in vitro of th e oxygen consumption capacity. 
It was observed that exposure to crystal violet for 5 minutes resulted in 
decreased oxygen consumption, being more marked with t ime after expo­
sure. Reasonable explanations can be either a disturbance of th e energy 
metabolism dominant in these cells (glucose intermediary metabolism and 
mitochondrial function) or an adaptation to less energy demands resulting 
from decreased cytoplasmic protein synthesis as evidenced by the reduced 
14 incorporation of C-proline into collagen and non-collagenous proteins. 
The synthesis of RNA was also reduced. It was thus possible to analyse in 
somewhat greater detail the immediate modifications of th e cellular bio­
chemical processes induced by crystal violet, which finally will result in 
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gross tissue damage. It must be observed, however, that further work is 
needed to explore the primary effect of th e dye on specific cellular con­
stituents. Although the body of ev idence seems to support a direct cell 
influence it must be cautioned that the results obtained could partly be due 
to an influence on the intercellular ground substance leading to a decrea­
sing passage of n utrients to the cell and changing the milieu for aggrega­
tion of co llagen fibrils (c. f. Preston & Snowden 1973). 
A cy totoxic effect of c rystal violet on exposed tissue seems thus to be 
clearly demonstrated in these experimental models. A few parallel experi­
ments have been done with related compounds, which turned out to be 
generally equivalent as regard their tissue damaging effect. The dyes 
tested were brilliant green (I, II, IV), methyl violet 2B (II ) and basic 
fuchsin (Björnberg & Mobacken 1972). 
Theoretically, there is a risk that the decreased tissue viability inflicted 
by a triphenylmethane dye will make the traumatized tissue more infectable 
(Burke 1964), e.g. from surviving gram-negative bacteria. This point 
deserves further study, as a recent increase in Pseudomonas infections 
has been reported in dermatologie practice (Noble & Savin 1971). 
The experimental studies thus demonstrate that crystal violet and related 
triphenylmethane dyes in concentrations well below those used in clinical 
practice under certain circumstances can induce considerable tissue da­
mage. Certainly different species of a nimals were used in the experiments 
but the healing process, being a basic biological function, is considered not 
to differ qualitatively between them and man (Howes, Harvey & Hewitt 1939). 
This is corroborated by the congruent results in humans and guinea pigs 
(I). Consequently, it seems reasonable to assume, that the results of the 
experimental studies should in principle be valid for humans too. Con­
sidering the widespread use of c rystal violet and its irritant potency, it 
remains to be explained why t issue damage is not more frequently reported 
in the literature or observed in practical work. The degree of t issue da­
mage will be influenced by several factors. Such factors of o bvious 
i m p o r t a n c e  a r e :  th e  c o n c e n t r a t i o n  o f  t h e  d y e  a n d  e x p o s u r e  t i m e  ( I ,  I I ) ,  
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the concentration of dye neutralizing substances such as serum and poly-
anionic tissue components (II), the condition of the treated tissue (I) and 
the occurrence of occlusion (c. f. Wahlberg 1973). Regional variations in 
percutaneous penetration of va rious compounds exist between different 
body regions (Cronin & Stoughton 1962, Winkelmann 1969); the scrotal 
skin being particularly penetrable (Smith, Fischer & Blank 1961, Wahl­
berg 1973). Besides, some individuals seem to have a constitutionally 
x/ increased sensitivity to certain primary irritants according to clinical 
and experimental findings (Kligman 1963, Björnberg 1968). A generalized, 
unspecific increase in skin reactivity ("status eczematicus") can tempo­
rarily arise as a consequence of localized eczemas, rendering not ob­
viously affected skin more susceptible to primary irritants (Björnberg 
1968), and add to the risk of un expected side effects from therapeutic 
agents. 
The demonstration of the tissue-damaging effect of the triphenylmethane 
dyes will, when added to other disadvantages such as discolouring and 
masking, probably make them clinically less common. However, this 
should not preclude their use, as long as one is aware of the possible in­
jurious effect and precautions are taken to reduce this risk. 
The experimental models used in this investigation may be useful for the 
study of tissue-damaging effects of ot her topical drugs. Exploration of t he 
possible tissue-irritating effects along the lines presented here of new 
chemicals intended for clinical use may be helpful in revealing even weak 
irritants and create opportunities for taking adequate precautions before 
their use in humans. 
x/ Primary irritants are substances which damage skin by direct action 
(Kligman & Wooding 1967). 
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SUMMARY AND CONCLUSIONS 
The purpose of the present investigation was to study the influence of 
triphenylmethane dyes on normal and reparative tissue. The impetus 
was the clinical observation (I) that necrotic ulcerations sometimes 
develop in treated areas, a little known complication. It was possible 
to reproduce the necrotic reaction in man and guinea pig by painting an 
aqueous solution of c rystal violet on skin where the stratum corneum had 
been stripped away with adhesive tape (I). "Unstripped" skin showed no 
reaction, which indicates a poor penetrability into normal skin. 
The tissue-damaging effect was further studied by implanting viscose 
cellulose sponges subcutaneously in rats (III). Exposure of th e sponge 
or the surrounding tissue to crystal violet resulted in a pronounced reduc­
tion of t he breaking load over a defined tissue bridge in the sponge. Micro­
scopically, the sponges contained a serofibrinous oedema with inflamma­
tory cells and appeared devoid of new ly formed connective tissue. 
The significance of t his observation for wound healing was evaluated by 
exposing incisional wounds in rat skin to the dye for 5 minutes (IV). 
Healing, as measured by breaking load, was still retarded after 21 days. 
The lag phase was prolonged due to an intensified and lengthened post­
traumatic inflammatory reaction. This delayed the onset of fi broplasia, 
but, once started, it proceeded at a fairly normal rate. Morphologically 
there was evidence of slower maturation of gr anulation tissue. The results 
are probably valid also for open wounds. 
The mechanism behind the deleterious tissue effect of c rystal violet and 
related triphenylmethane dyes was studied by a tissue-culture technique 
(II). The dyes were strongly cytotoxic against fibroblast-like cells and 
HeLa-cells. Exposure for 5 minutes was sufficient to hamper the multi­
plication of c ells; increasing exposure times produced further decrease 
of t he number of c ell colonies. High concentrations of s erum and 
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polyanionic tissue components (heparin, chondroitin sulphate) partly re­
duced the cytotoxic effect. These substances may constitute a tissue 
protective factor when triphenylmethane dyes are used clinically. The 
cytotoxicity was not reduced in dense, topo-inhibited cultures as com­
pared with vigorously proliferating cell populations, suggesting that 
crystal violet affects basic cell functions and not only DNA-synthesizing 
or dividing cells. This was analysed in greater detail in granulation tissue 
14 by measuring the capacities to consume oxygen, to incorporate C-
proline into collagen and non-collagenous proteins and to synthesize RNA 
(V). These processes were markedly reduced by crystal violet. 
The experimental models demonstrate a tissue-damaging capacity of 
triphenylmethane dyes in concentrations well below those used clinically. 
This fact must be paid attention to when therapeutic alternatives are 
discussed in clinical practice. It should not preclude their use, however, 
as long as one is aware of t he possible injurious effect and take pre­
cautions to reduce this risk. 
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